Literature DB >> 475455

Sialyltransferase levels and sialic acid concentrations in sera of patients with malignant melanomas.

W P Herrmann, W Gielen.   

Abstract

Serum levels of sialyltransferase and sialic acid were measured in patients with malignant melanomas (n = 49), healthy control persons (n = 20), and patients with non-malignant skin disorders (n = 30). Both parameters were found to be higher in malignant melanoma patients than in healthy control persons, but they were not significantly higher in melanoma patients than in patients with benign skin disorders, unless widespread dissemination of metastases had occurred. The highest values were measured in patients with liver and lung metastases. No general correlation was found between sialyltransferase activities and sialic acid concentrations. Sialic acid concentrations seem to be a better index for tumor spreading than sialyltransferase activities. In early stages of the disease, shedding from tumor cells is not the major source of elevated serum levels of sialyltransferase and sialic acid, respectively.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475455     DOI: 10.1007/bf00412390

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  A comparison of glycosyltransferase activities and malignant properties in normal and transformed cells derived from BALB/c mice.

Authors:  L M Patt; G A Van Nest; W J Grimes
Journal:  Cancer Res       Date:  1975-02       Impact factor: 12.701

2.  [The clinical application of serum sialyl transferase determination as criterion of malignant transformation of cell surface structure (author's transl)].

Authors:  U Ganzinger
Journal:  Wien Klin Wochenschr       Date:  1977-09-16       Impact factor: 1.704

3.  Elevated activity of cytidine 5'-monophospho-N-acetylneuraminic acid hydrolase in serum of ovarian cancer patients as a possible indicator of malignancy.

Authors:  S K Chatterjee; M Bhattacharya; J J Barlow
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

4.  Alterations in plasma sialyltransferase levels in patients with neoplastic disease.

Authors:  M Henderson; D Kessel
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

5.  [Elevated serum-sialyltransferase activity in human malignant diseases: a new diagnostic tool? (author's transl)].

Authors:  U Ganzinger; F Dorner; F M Unger; K Moser; K Jentzsch
Journal:  Klin Wochenschr       Date:  1977-06-01

Review 6.  Biochemical properties of normal and neoplastic cell surfaces; a review.

Authors:  P Emmelot
Journal:  Eur J Cancer       Date:  1973-05       Impact factor: 9.162

7.  Sialyl transferase activity in normal and RNA- and DNA-virus transformed cells utilizing desialyzed, trypsinized cell plasma membrane external surface glycoproteins as exogenous acceptors.

Authors:  H B Bosmann
Journal:  Biochem Biophys Res Commun       Date:  1972-12-04       Impact factor: 3.575

8.  Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase.

Authors:  L Warren; J P Fuhrer; C A Buck
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

9.  Properties of a CMP-N-acetylneuraminic acid: glycoprotein sialyltransferase in human serum and erythrocyte membranes.

Authors:  Y S Kim; J Perdomo; A Bella; J Nordberg
Journal:  Biochim Biophys Acta       Date:  1971-09-21

10.  Serum sialic acid elevations in malignant melanoma patients.

Authors:  H K Silver; D M Rangel; D L Morton
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

View more
  2 in total

1.  An animal model for the survival of tyrosinase isozymes in serum.

Authors:  J Vachtenheim; J Duchon; B Matous
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells.

Authors:  Minyoung Lee; Jung-Jin Park; Young-Gyu Ko; Yun-Sil Lee
Journal:  Radiat Oncol       Date:  2012-03-27       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.